查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526334

全球生命科學工具市場

Life Science Tools
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 849 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球生命科學工具市場預計將達到 2,646 億美元

2023年全球生命科學工具市場估計為1,512億美元，預計到2030年將達到2,646億美元，2023年至2030年複合年成長率為8.3%。細胞生物學技術是本報告分析的細分領域之一，預計複合年成長率為 7.4%，到分析期結束時將達到 846 億美元。分析期間，基因組學技術領域的複合年成長率預計為 8.6%。

美國市場預計535億美元，中國預計複合年成長率12.5%

預計 2023 年美國生命科學工具市場規模將達 535 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達311億美元，2023-2030年分析期間複合年成長率為12.5%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 6.0% 和 7.7%。在歐洲，德國預計複合年成長率為 7.1%。

全球生命科學工具市場 - 主要趨勢與促進因素總結

生命科學工具涵蓋用於研究生物系統的廣泛技術和設備。這些工具包括先進的實驗室設備、試劑、消耗品以及研究和臨床環境中使用的軟體。生命科學工具的關鍵組成部分是基因組學和蛋白​​質組學技術，分別包括 DNA序列測定和蛋白質分析。這些工具透過實現更準確、更有效率的調查方法，徹底改變了生物技術、醫學和診斷等領域。高通量篩檢、質譜和先進的成像技術對於生命科學研究至關重要，可以提供對細胞和分子過程的詳細見解。將這些工具與生物資訊學相結合，使研究人員能夠分析大型資料集，從而在了解疾病和開發標標靶治療取得重大進展。隨著用於癌症治療的單株抗體受到越來越多的關注，全球市場預計將進一步擴大。近年來，許多單株抗體已被核准作為各種癌症的治療劑。這些診斷和癌症治療的核准預計將擴大生技藥品的應用範圍。

生命科學工具的主要創新之一是次世代定序儀(NGS) 技術的出現。 NGS 大大降低了基因組序列測定所需的成本和時間，促進了大規模基因組計劃和個人化醫療的方法。另一個重要的進步是 CRISPR-Cas9。 CRISPR-Cas9 是一種基因編輯技術，為基因研究和治療開闢了新途徑。此外，單細胞分析工具使科學家能夠以前所未有的細節研究細胞群的異質性，這對於理解癌症等複雜疾病至關重要。晶片實驗室技術的發展使許多實驗室流程實現了小型化和自動化，提高了效率並減少了對大樣本量的需求。這些創新得到了強大的軟體工具的支持，用於管理和解釋產生的大量資料，從而能夠從可行的見解中得出複雜的生物資訊。

生命科學工具市場的成長受到多種因素的推動，例如個人化醫療需求的成長、研發投資的增加以及技術進步。個人化醫療根據個人的遺傳特徵客製化治療方法，在很大程度上依賴基因組和蛋白質組學工具，並正在推動這些領域的需求。來自政府機構、私人組織和創業投資的大量資金正在刺激研究計劃和新工具的開發。人工智慧和機器學習演算法的發展等技術進步正在增強資料分析能力並加快發現過程。慢性病盛行率的不斷上升以及對創新診斷和治療解決方案的需求也是關鍵促進因素。此外，生物技術和製藥行業的擴張，加上新興市場擴大採用生命科學工具，也促進了市場的成長。隨著這些工具變得更容易獲取並整合到各種研究和臨床應用中，它們對健康和疾病管理的影響持續成長，推動了該領域的進一步發展。

受訪企業範例（共295家）

  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments plc
  • PerkinElmer Inc.
  • QIAGEN NV
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP22151

Global Life Science Tools Market to Reach US$264.6 Billion by 2030

The global market for Life Science Tools estimated at US$151.2 Billion in the year 2023, is expected to reach US$264.6 Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Cell Biology Technology, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$84.6 Billion by the end of the analysis period. Growth in the Genomics Technology segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$53.5 Billion While China is Forecast to Grow at 12.5% CAGR

The Life Science Tools market in the U.S. is estimated at US$53.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$31.1 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.0% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Global Life Science Tools Market - Key Trends & Drivers Summarized

Life science tools encompass a broad spectrum of technologies and instruments used in the study of biological systems. These tools include advanced laboratory instruments, reagents, consumables, and software used in research and clinical settings. Key components of life science tools are genomics and proteomics technologies, which involve DNA sequencing and protein analysis respectively. These tools have revolutionized fields such as biotechnology, pharmaceuticals, and diagnostics by enabling more precise and efficient research methodologies. High-throughput screening, mass spectrometry, and advanced imaging techniques are integral to life science research, providing detailed insights into cellular and molecular processes. The integration of these tools with bioinformatics allows researchers to analyze large datasets, leading to significant advancements in understanding diseases and developing targeted therapies. The global market is expected to gain further from increasing attention on monoclonal antibodies for cancer therapy. In the recent years, a large number of monoclonal antibodies have secured the regulatory approval for treatment of different forms of cancer. These approvals for diagnosis and cancer therapy are slated to expand the application scope of biologics.

One of the major innovations in life science tools is the advent of next-generation sequencing (NGS) technologies. NGS has dramatically reduced the cost and time required for sequencing genomes, facilitating large-scale genomic projects and personalized medicine approaches. Another critical advancement is CRISPR-Cas9, a gene-editing technology that has opened new avenues for genetic research and therapy. Additionally, single-cell analysis tools are enabling scientists to study the heterogeneity of cell populations in unprecedented detail, which is crucial for understanding complex diseases such as cancer. The development of lab-on-a-chip technologies has miniaturized and automated many laboratory processes, increasing efficiency and reducing the need for large sample volumes. These innovations are supported by robust software tools that manage and interpret the vast amounts of data generated, making it possible to derive actionable insights from complex biological information.

The growth in the life science tools market is driven by several factors, including the increasing demand for personalized medicine, rising investments in research and development, and advancements in technology. Personalized medicine, which tailors treatments to individual genetic profiles, relies heavily on genomic and proteomic tools, driving demand in these areas. Significant funding from government bodies, private organizations, and venture capitalists is fueling research initiatives and the development of new tools. Technological advancements, such as the development of AI and machine learning algorithms, are enhancing data analysis capabilities and speeding up the discovery process. The growing prevalence of chronic diseases and the need for innovative diagnostic and therapeutic solutions are also key drivers. Furthermore, the expansion of biotechnology and pharmaceutical industries, coupled with the increasing adoption of life science tools in emerging markets, is contributing to market growth. As these tools become more accessible and integrated into various research and clinical applications, their impact on health and disease management continues to grow, propelling further advancements in the field.

Select Competitors (Total 295 Featured) -

  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments plc
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • A Prelude to Life Sciences Tools
    • Global Economic Update
    • Competition
    • Players Pursue Product Launch & Innovation to Stay Relevant in Competitive Life Science Tools Market
    • Life Science Tools - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Market Analysis and Prospects
    • Global Life Science Tools Market Appears Primed for Healthy Growth Ahead
    • Cell Biology Holds Significant Revenue Stake
    • Hospitals Remain Primary End-User Segment
    • North America Maintains Front Rank in Global Life Science Tools Market
    • Asia-Pacific to Exhibit Impressive Growth
    • Salient Drivers Keeping Global Life Science Tools Market in Good Shape
    • Technology Trends in the Life Sciences Domain
    • Connected Devices, IoT Ecosystems to Transform the Life Science Landscape
    • Exponential Intelligence, Quantum Computing and Ambient Technologies to Make Headway
    • Cloud Platforms Ease Data Sharing
    • Life Sciences to Gain with Blockchain Edge
    • AI-enabled Automation to Deliver Tangible Benefits for All
    • Cybersecurity Needs Grow for Life Sciences
    • Intertwined Factors with Major Implications for Life Science Domain & Related Tools
    • Recent Market Activity
    • World Brands
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Trends in Life Science Sector Support Demand
    • Why Diagnostic Testing is Key to Mitigate Impact of Infectious Diseases?
    • 3D Cell Culture Transforms Life Sciences Industry
    • Global 3D Cell Culture Market in US$ Million: 2020 - 2027
    • Increasing Demand for 3D Cell Culture in Drug Discovery
    • Use of 3D Cell Culture for Regenerative Medicine
    • mRNA Technology Gains Spotlight in Life Sciences
    • Innovations in Instrumentation Expand Functionality and Drive Adoption of PCR
    • Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years
    • Global qPCR and dPCR Instrumentation Market in US$ Million: 2020-2025
    • Genome Sequencing Experiences Host of Evolutionary Waves
    • Greater Integration of Genomic Technologies in the Development of Novel Diagnostics Tests
    • Next Generation Sequencing Drives the Market Growth
    • R&D Activity Remains Vibrant in NGS
    • The Need for Large-scale NGS Data Analysis Pushes for Cloud-enabled Bioinformatics Services
    • Single-Cell Spatial Biology Technologies Poised to Emerge as an Integral Aspect of Future Labs
    • Rising Application of Whole Genome Sequencing Drives Demand for Faster Secondary Analysis Tools
    • Rapid Growth in Biopharma Industry and Rising Investments in R&D to Boost Market Prospects
    • Global BioPharmaceuticals Market in US$ Billion: 2020 and 2026
    • Liquid Chromatography Drives Growth in New Application Markets
    • Innovative HPLC Products Inject New Growth
    • Digital Transformation of Life Sciences Sector Improves Efficiency and Productivity
    • Key Initiators of Digital Transformation in Life Sciences
    • Artificial Intelligence offers Multiple Opportunities
    • Wearable Devices Gains Popularity
    • The Cloud Technology Witnesses Rapid Growth
    • VR and E-pharmacy
    • Smart Quality
    • Growing R&D Spending in Pharma and Biotechnology Sectors Presents Opportunities
    • Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
    • Technological Developments and Expanding End-Use Applications to Bolster Growth in Mass Spectrometry
    • Global Chromatography Market (2022): Percentage Share Breakdown of Value Sales by Chromatography Techniques
    • Miniature Mass Spectroscopy Instruments Get Popular
    • Increase in Healthcare Spending to Propel Demand for Life Science Tools
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • The Rise of Data Analytics in Life Sciences
    • Data Science in Drug R&D
    • Data Sharing Emerges as a Significant Trend to Gain Competitive Advantage
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Life Science Tools Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Cell Biology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Healthcare by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Government & Academics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Life Science Tools by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • TABLE 62: France Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Life Science Tools by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 143: Middle East Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Middle East Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Middle East 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 146: Middle East Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Middle East Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Middle East 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • TABLE 149: Africa Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Africa Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Africa 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 152: Africa Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Africa Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Africa 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION